Market Overview:
The global STDs diagnosis market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of STDs, growing awareness about STDs and their prevention, and technological advancements in the field of STD diagnosis. The global STD diagnosis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into gonorrhea testing, human papilloma virus (HPV) testing, chlamydia testing, chancroid testing, and other tests. HPV Testing is expected to be one of fastest-growing segments during the forecast period owing to rising prevalence rates for HPV infections globally. On the basis of application; POC Testing accounted for a larger share in 2017 and it is projected that this trend will continue duringthe forecast period as well).
Product Definition:
An STD is a sexually transmitted disease. It is often abbreviated as STI, which stands for sexually transmitted infection.
A diagnosis of an STD means that you have been infected with a disease that can be passed on through sexual contact. Getting tested and treated for STDs is important because they can cause serious health problems if left untreated.
Gonorrhea Testing :
Gonorrhea testing is used for detecting gonococcal infections. It's the main diagnostic test for gonorrhea and chlamydia. Gonorrhea can be diagnosed by different tests such as culture, antibody detection, serology, and flow cytometry among others. The most commonly used method of diagnosis is the enzyme linked immunosorbent assay (ELISA).
The global gonorrhea testing market size was valued at USD 740 million in 2016.
Human Papilloma Virus (HPV) Testing:
Human papilloma virus (HPV) testing and its usage in the diagnosis of STDs are covered under the category of rare diseases. The incidence rate of these diseases is less, hence there is no specific treatment available for them. Diagnosis can be made based on symptoms presented by infected patients or through detection of viral particles in samples taken from affected areas.
Application Insights:
Based on application, the global market is segmented into point-of-care testing, laboratory testing and others. The other segment includes research studies related to syphilis, gonorrhea and chlamydia. Point-of-care tests are preferred for diagnosis of STDs as they require less sample volume than laboratory tests and are more convenient since they can be performed at the time of consultation or during an outpatient appointment at a healthcare facility.
The growing preference for POC testing is attributed to its convenience along with its ability to detect infections even in early stages when there may not be enough blood/fluid available in the body for conventional lab tests. Moreover, these types of diagnostic kits can also detect infections that would have otherwise gone undetected due to insufficient specimen collection or inadequate processing by laboratories. These factors are anticipated to boost product demand over the forecast period (2017 To 2030).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing prevalence of sexually transmitted diseases, rising awareness about these infections, and availability of effective treatment in this region. For instance, according to a study published by National Center for Health Statistics (NCHS), around 6.3 million people were diagnosed with chlamydia in U.S., which is approximately 11% increase from 2013.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase number of STDs cases being reported among population groups at higher risk such as youth & young adults (15-24 years).
Growth Factors:
- Increasing incidence of STDs: The incidence of STDs is increasing at an alarming rate across the globe. This is primarily due to changing sexual behavior and lack of awareness about safe sex practices. This is expected to drive the demand for STD diagnosis market in the coming years.
- Growing public awareness: There has been a growing public awareness about STDs in recent years, owing to increasing incidences of these diseases and campaigns by various organizations to spread awareness about them. This is expected to boost the demand for STD diagnosis market in the near future.
- Rising prevalence of HIV/AIDS: The prevalence of HIV/AIDS continues to be a major concern across the world, especially in developing countries where access to treatment and care remains limited. This is likely to fuel demand for STD diagnosis market over the forecast period as it can help identify early signs and symptoms associated with HIV/AIDS infection, which can improve chances for timely treatment and prevention from further complications caused by AIDS virus infection.. 4) Technological advancements: Technological advancements are helping improve accuracy levels of tests performed for diagnosing different types or strains on sexually transmitted infections (STIs). For instance, polymerase chain reaction (PCR) technology helps detect minute traces DNA from pathogens that cause infections such as chlamydia, gonorrhea etc., thus improving accuracy levelsof test results .Thisis likelyto propel growth prospectsforSTDdiagnosismarketin thenearfuture 5) Rising numberof partnershipsand
Scope Of The Report
Report Attributes
Report Details
Report Title
STDs Diagnosis Market Research Report
By Type
Gonorrhea Testing , Human Papilloma Virus (HPV) Testing, Chlamydia Testing, Chancroid Testing, Other
By Application
Point-Of-Care (POC) Testing, Laboratory Testing
By Companies
Becton, Dickinson, Roche Diagnostics, Biomerieux , Gen-Probe, Beckman Coulter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global STDs Diagnosis Market Report Segments:
The global STDs Diagnosis market is segmented on the basis of:
Types
Gonorrhea Testing , Human Papilloma Virus (HPV) Testing, Chlamydia Testing, Chancroid Testing, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Point-Of-Care (POC) Testing, Laboratory Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton
- Dickinson
- Roche Diagnostics
- BiomerieuxÂ
- Gen-Probe
- Beckman Coulter
Highlights of The STDs Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gonorrhea TestingÂ
- Human Papilloma Virus (HPV) Testing
- Chlamydia Testing
- Chancroid Testing
- Other
- By Application:
- Point-Of-Care (POC) Testing
- Laboratory Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the STDs Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
STD diagnosis is the process of confirming that a person has an STD. This can be done through a variety of methods, including testing for specific antibodies or other markers associated with STDs.
Some of the major companies in the stds diagnosis market are Becton, Dickinson, Roche Diagnostics, Biomerieux‚Â , Gen-Probe, Beckman Coulter.
The stds diagnosis market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. STDs Diagnosis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. STDs Diagnosis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. STDs Diagnosis Market - Supply Chain
4.5. Global STDs Diagnosis Market Forecast
4.5.1. STDs Diagnosis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. STDs Diagnosis Market Size (000 Units) and Y-o-Y Growth
4.5.3. STDs Diagnosis Market Absolute $ Opportunity
5. Global STDs Diagnosis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. STDs Diagnosis Market Size and Volume Forecast by Type
5.3.1. Gonorrhea Testing
5.3.2. Human Papilloma Virus (HPV) Testing
5.3.3. Chlamydia Testing
5.3.4. Chancroid Testing
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global STDs Diagnosis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. STDs Diagnosis Market Size and Volume Forecast by Application
6.3.1. Point-Of-Care (POC) Testing
6.3.2. Laboratory Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global STDs Diagnosis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. STDs Diagnosis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global STDs Diagnosis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. STDs Diagnosis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global STDs Diagnosis Demand Share Forecast, 2019-2026
9. North America STDs Diagnosis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America STDs Diagnosis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America STDs Diagnosis Market Size and Volume Forecast by Application
9.4.1. Point-Of-Care (POC) Testing
9.4.2. Laboratory Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America STDs Diagnosis Market Size and Volume Forecast by Type
9.7.1. Gonorrhea Testing
9.7.2. Human Papilloma Virus (HPV) Testing
9.7.3. Chlamydia Testing
9.7.4. Chancroid Testing
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America STDs Diagnosis Demand Share Forecast, 2019-2026
10. Latin America STDs Diagnosis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America STDs Diagnosis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America STDs Diagnosis Market Size and Volume Forecast by Application
10.4.1. Point-Of-Care (POC) Testing
10.4.2. Laboratory Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America STDs Diagnosis Market Size and Volume Forecast by Type
10.7.1. Gonorrhea Testing
10.7.2. Human Papilloma Virus (HPV) Testing
10.7.3. Chlamydia Testing
10.7.4. Chancroid Testing
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America STDs Diagnosis Demand Share Forecast, 2019-2026
11. Europe STDs Diagnosis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe STDs Diagnosis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe STDs Diagnosis Market Size and Volume Forecast by Application
11.4.1. Point-Of-Care (POC) Testing
11.4.2. Laboratory Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe STDs Diagnosis Market Size and Volume Forecast by Type
11.7.1. Gonorrhea Testing
11.7.2. Human Papilloma Virus (HPV) Testing
11.7.3. Chlamydia Testing
11.7.4. Chancroid Testing
11.7.5. Other
11.8. Basis Point Share (BPS) Analyss by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe STDs Diagnosis Demand Share, 2019-2026
12. Asia Pacific STDs Diagnosis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific STDs Diagnosis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific STDs Diagnosis Market Size and Volume Forecast by Application
12.4.1. Point-Of-Care (POC) Testing
12.4.2. Laboratory Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific STDs Diagnosis Market Size and Volume Forecast by Type
12.7.1. Gonorrhea Testing
12.7.2. Human Papilloma Virus (HPV) Testing
12.7.3. Chlamydia Testing
12.7.4. Chancroid Testing
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific STDs Diagnosis Demand Share, 2019-2026
13. Middle East & Africa STDs Diagnosis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa STDs Diagnosis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa STDs Diagnosis Market Size and Volume Forecast by Application
13.4.1. Point-Of-Care (POC) Testing
13.4.2. Laboratory Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa STDs Diagnosis Market Size and Volume Forecast by Type
13.7.1. Gonorrhea Testing
13.7.2. Human Papilloma Virus (HPV) Testing
13.7.3. Chlamydia Testing
13.7.4. Chancroid Testing
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa STDs Diagnosis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global STDs Diagnosis Market: Market Share Analysis
14.2. STDs Diagnosis Distributors and Customers
14.3. STDs Diagnosis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Becton
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dickinson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biomerieux
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gen-Probe
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckman Coulter
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
